New Prognostic Marker Identified for Advanced Lung Adenocarcinoma
A groundbreaking study identifies perilipin 2 as a key factor in the progression of advanced lung adenocarcinoma, highlighting its potential as a prognostic marker and therapeutic target.
Recent research has uncovered that the protein perilipin 2 significantly influences the progression of advanced lung adenocarcinoma, which is the most prevalent form of lung cancer. The study highlights that perilipin 2 regulates lipid droplet accumulation within cancer cells—a process integral to lipid metabolism. This accumulation enables cancer cells to store more fat, providing a vital energy source that fuels tumor growth and aggressiveness.
In the research published in The American Journal of Pathology, scientists observed that increased perilipin 2 expression correlated with more aggressive disease progression and shorter recurrence-free survival among patients. Analyzing 214 tissue samples collected from lung adenocarcinoma patients who underwent surgery between 2010 and 2016, they found that 65 samples were perilipin 2 positive, while 149 were negative.
Further experiments showed that knocking out PLIN2 in lung cancer cell lines reduced lipid droplet formation and significantly decreased cell proliferation and migration. These findings suggest that perilipin 2 is crucial for maintaining lipid droplets, which act as an energy reservoir to drive tumor growth. Hence, perilipin 2 could serve as a valuable prognostic marker and a potential therapeutic target.
Lung cancer remains a major health challenge worldwide, with high mortality rates. While some patients benefit from targeted therapies specific to certain genetic mutations, many lack these mutations and are unresponsive to current treatments. The identification of perilipin 2 opens new avenues for personalized treatment approaches focused on lipid metabolism. Dr. Kana Miyata-Morita from Teikyo University emphasizes that understanding lipid-related mechanisms in lung adenocarcinoma could lead to better prediction of disease recurrence and the development of novel therapies based on lipid targets.
This emerging research underscores the importance of exploring metabolic processes in cancer progression and offers hope for improved management of lung adenocarcinoma in the future.
Source: https://medicalxpress.com/news/2025-08-reveals-prognostic-factor-advanced-lung.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
The True Cost of Dementia: Unpaid Care Falling on Family and Friends Reaches $224 Billion
Family and friends provide unpaid care for dementia patients, totaling an estimated $224 billion annually in the U.S., revealing substantial regional disparities and highlighting the need for better caregiver support.
Discovery of Specialized Lung Cells Accelerates Repair After Smoke and Virus Exposure in Mice
Scientists have identified rare lung neuroendocrine cells that trigger rapid repair after exposure to smoke and viruses, with potential implications for respiratory health and metabolic disease prevention.
Understanding the Summer COVID Surge and the 'Razor Blade Throat' Phenomenon
Summer COVID-19 cases are rising, with the NB.1.8.1 variant causing a distinctive 'razor blade throat.' Despite increased transmission, hospitalizations and deaths remain low thanks to vaccines and ongoing health measures.
Innovative Light-Based Technique Targets and Eliminates Cancer Cells
Researchers have developed a revolutionary light-activated drug system to target and kill melanoma and triple-negative breast cancer cells with high precision, minimizing healthy tissue damage.